Dr. Sayon Roy received his PhD from Boston University and completed his postdoctoral training at Schepens Eye Research Institute, Harvard Medical School, Harvard University. Dr. Roy is currently a professor of Medicine, Section of Diabetes, Endocrinology and Nutrition and a professor of Ophthalmology at Boston University School of Medicine. Recognized as an expert in retinal vascular biology, Dr. Roy’s seminal work has identified several genes in the retina that are abnormally expressed in diabetic retinopathy. His pioneering work has led to novel gene modulatory techniques in retinal vascular cells using antisense oligonucleotides via intravitreal injection. Dr. Roy has received numerous awards including the American Diabetes Association Research Award for the commitment and dedication towards the fight against diabetes, the 2006 Mentor of the Year Award from Boston University, and the 2008 Innovative Award from the Juvenile Diabetes Research Foundation. Research in Dr. Roy’s laboratory has been funded by several organizations including the National Eye Institute, NIH, National Medical Technology Testbed, American Diabetes Association, Juvenile Diabetes Research Foundation International, Fight for Sight, Research to Prevent Blindness, and the Lions Organization. Dr. Roy currently serves as a chartered member of the NEI Study Section of the National Institutes of Health.

Research interest of Sayon Roy include Vascular basement membrane thickening is a prominent and characteristic lesion of diabetic retinopathy. We have hypothesized that excess synthesis of basement membrane components occurring in diabetes is a critical pathogenetic event in the development of vascular basement membrane thickening and complications of diabetic retinopathy. Having shown that the mRNA level of basement membrane components fibronectin and collagen IV are increased in diabetic retinas, our laboratory plans to reduce the synthesis of these basement membrane.

1. What makes an article top quality? 

Response: Good scientific data that improves the understanding of a specific field.

2. Do you think that journals determine research trends?

Response: No. New research findings and novel technologies determine research trends.

3. What makes a good position paper?

Response: This question is unclear.

4. What are the qualities you look for in an article?

Response: In-depth analysis of the question the paper is attempting to answer.

5. Can you give us a broad indication of the types of themes a scientific journal should cover?

Response: Themes should focus on ocular diseases that are devastating and affect many people. Of course, rare diseases should also be thematic focus - however, this may not be published at the same frequency.

6. What sorts of research methods and frameworks do you expect people to use, and how will they balance conceptual and applied research?

Response: This should be the "mission statement" of the journal.

7. How would you describe the journal’s mission and editorial objectives to our readers?

Response: Mechanisms of ocular disease processes.

8. If you could be granted dream articles, what would they be on?

Response: This depends largely on the interest of the practitioners.

9. Are there any particular areas which you would like to see, or expect to see, collaborate?

Response: Transparency - maintains records of the peer-review process and make them available if needed.

10. How does the research published percolate through to practitioners?

Response: Research and clinical findings from around the globe should be encouraged for publication in this journal.

11. What do you see as the merits of journals, as opposed to book series, as a means of scholarly communications?

Response: Rapid dissemination of new findings.

12. How do you differentiate International Journal of Ophthalmic Pathology with other journals in the field?

Response: This journal specializes in topics related to pathological issues in ocular complications.